Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon

NCT01845701 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

720

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artesunate-Amodiaquine
DRUG: Dihydroartemisinine-Piperaquine
DRUG: Artemether-lumefantrine combination

Sponsor

University of Yaounde 1

Collaborators

[object Object]
[object Object]